MIRUM PHARMACEUTICALS INC - NOTE 4.000% 5/0

CUSIP: 604749AB7

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Debt / NOTE 4.000% 5/0
Market price (% of par)
152.25%
Total 13F principal
$296,243,895
Principal change
-$3,294,050
Total reported market value
$450,609,974
Number of holders
35
Value change
-$6,400,893
Number of buys
8
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 604749AB7?
CUSIP 604749AB7 identifies 604749AB7 - MIRUM PHARMACEUTICALS INC - NOTE 4.000% 5/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MIRUM PHARMACEUTICALS INC - NOTE 4.000% 5/0 as of Q4 2024

As of 31 Dec 2024, MIRUM PHARMACEUTICALS INC - NOTE 4.000% 5/0 was held by 35 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $296,243,895 in principal (par value) of the bond. The largest 10 bondholders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), WOLVERINE ASSET MANAGEMENT LLC, READYSTATE ASSET MANAGEMENT LP, MACKAY SHIELDS LLC, FRANKLIN RESOURCES INC, Point72 Asset Management, L.P., AMERIPRISE FINANCIAL INC, FMR LLC, BNP PARIBAS FINANCIAL MARKETS, and SSI INVESTMENT MANAGEMENT LLC. This page lists 35 institutional bondholders reporting positions for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.